Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
35,96 USD | +1,78% | +2,98% | +25,38% |
12/04 | REVOLUTION MEDICINES, INC. : prospettiva positiva di Oppenheimer | ZM |
12/04 | REVOLUTION MEDICINES, INC. : Needham & Co. rimane Buy | ZM |
Attività
Numero di dipendenti: 378
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Targeted Therapies
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 01/08/18 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/15 |
Wei Lin
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/04/23 |
Steve Kelsey
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/03/17 |
Peg Horn
COO | Chief Operating Officer | 61 | - |
Linnet Zia
PRN | Corporate Officer/Principal | - | 01/03/19 |
Jeff Cislini
LAW | General Counsel | 49 | 01/01/20 |
Daniel Simon
PRN | Corporate Officer/Principal | - | 01/09/22 |
Luan M. Wilfong
HRO | Human Resources Officer | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Alexis Borisy
BRD | Director/Board Member | 52 | 01/11/14 |
Sandra Horning
BRD | Director/Board Member | 75 | 09/11 |
Barbara Weber
BRD | Director/Board Member | 67 | 01/04/18 |
Thilo Schroeder
BRD | Director/Board Member | 42 | 01/03/18 |
Lorence Kim
BRD | Director/Board Member | 49 | 12/07/22 |
Director/Board Member | 66 | 01/03/15 | |
Flavia Borellini
BRD | Director/Board Member | 65 | 22/06/21 |
Sushil Patel
BRD | Director/Board Member | 53 | 16/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 170 250 408 | 159 826 812 ( 93,88 %) | 5 560 000 ( 3,266 %) | 93,88 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+25,38% | 6,13 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione RVMD
- Società Revolution Medicines, Inc.